Use of vasopressor agents to increase somatic blood flow.
D000818:Animals; D001012:Aorta, Abdominal; D001775:Blood Circulation / Q000187:drug effects*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008616:Mephentermine / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D008680:Metaraminol; D008729:Methoxamine; D007545:Isoproterenol; D008616:Mephentermine; D009638:Norepinephrine; D004837:Epinephrine